A Phase II Trial of Carboplatin, Pemetrexed, and Panitumumab in Patients With Advanced Non-Squamous K-ras Wild Type Non-Small-Cell Lung Cancer

Status
Active
Cancer Type
Lung Cancer
Trial Phase
Phase II
Eligibility
18 and over, Male and Female
Study Type
Treatment
NCD ID
NCT01042288
Protocol IDs
SCRI LUN 183 (primary)
Study Sponsor
Sarah Cannon Research Institute

Summary

The purpose of this multicenter, Phase II trial is to examine the role of a well-tolerated novel agent, panitumumab, in combination with a modern platinum doublet regimen using carboplatin and pemetrexed, in patients with advanced non-squamous wild type K-ras non-small-cell lung cancer (NSCLC). If this treatment proves to be well tolerated and associated with efficacy, this would provide rationale for further randomized studies.

Treatment Sites in Georgia


Longstreet Cancer Center - Gainesville
725 Jesse Jewel Parkway
3rd Floor
Gainesville, GA 30501
www.longstreetclinic.com

Study Coordinator:
Patti Rotunda
(770) 219-8826

Doctors:

Timothy M. Carey MD
Anup K. Lahiry MD
Richard J. LoCicero MD
Charles H. Nash, III MD, FACP

Northeast Georgia Diagnostic Clinic - Gainesville
1240 Jesse Jewell Parkway
Suite 500
Gainesville, GA 30501
www.ngdc.com

Study Coordinator:
Patti Rotunda
(770) 219-8826

Doctors:

Padma C. Nadella MD
Saloni H. Tanna MD
Christina A. Saurel MD

Surgical Oncology of Northeast Georgia
690 Medical Park Lane
Gainesville, GA 30501
www.drkendixon.com

Study Coordinator:
Patti Rotunda
(770) 219-8826

Doctors:

P. Kendal Dixon MD

Toccoa Cancer Center
1640 Falls Road
Toccoa, GA 30577
www.nghs.com

Study Coordinator:
Patti Rotunda
(770) 219-8826

Doctors:

Geoffrey J. Weidner MD